INTERIM REPORT
Period from January 2021 to March 2021 Lune Group OY incl subsidiary is consolidated in the group from 2020-06-03 Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED) Group, Lune Group OY incl subsidiary is included from 2020-06-03 2021 FIRST QUARTER (Jan-Mar) ·Net sales of products KSEK 11 381 (1 781) · Gross profit KSEK 6 568 (985), Gross margin 58% (55%) · Operating loss KSEK -6 424 (-5 807) · Loss per share SEK -0.03 (-0.04)From the CEO The first quarter of 2021 was marked by a number of events in order to continue to